These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 191524
1. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. O'Reilly RJ, Chibbaro A, Anger E, Lopez C. J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524 [Abstract] [Full Text] [Related]
2. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production. Sheridan JF, Aurelian L. Diagn Immunol; 1983 Mar; 1(3):245-56. PubMed ID: 6209056 [Abstract] [Full Text] [Related]
3. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets. Sheridan JF, Donnenberg AD, Aurelian L, Elpern DJ. J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224 [Abstract] [Full Text] [Related]
4. Leukocyte migration inhibitory factor in HSV infections. Centifanto YM, Zam ZS, McNeill JI, Kaufman HE. Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384 [Abstract] [Full Text] [Related]
7. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. Arvin AM, Pollard RB, Rasmussen LE, Merigan TC. J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336 [Abstract] [Full Text] [Related]
8. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. Rasmussen LE, Jordan GW, Stevens DA, Merigan TC. J Immunol; 1974 Feb; 112(2):728-36. PubMed ID: 4360547 [No Abstract] [Full Text] [Related]
11. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. Yasukawa M, Zarling JM. J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243 [Abstract] [Full Text] [Related]
12. Cellular immunity and herpesvirus infections in cardiac-transplant patients. Rand KH, Rasmussen LE, Pollard RB, Arvin A, Merigan TC. N Engl J Med; 1977 Jun 16; 296(24):1372-7. PubMed ID: 193008 [Abstract] [Full Text] [Related]
14. [Specific and unspecific immune stimulation in recurrent herpes simplex]. Raab W. Z Hautkr; 1977 May 15; 52(10):565-72. PubMed ID: 195407 [Abstract] [Full Text] [Related]
15. Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes. Fujibayashi T, Hooks JJ, Notkins AL. J Immunol; 1975 Nov 15; 115(5):1191-3. PubMed ID: 170341 [Abstract] [Full Text] [Related]
16. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition. Polack FM, Habash N, Zam ZS, Burdette MG. Ann Ophthalmol; 1982 Sep 15; 14(9):825-7. PubMed ID: 6295252 [Abstract] [Full Text] [Related]